165 related articles for article (PubMed ID: 22300659)
1. Small molecule inhibitors of the HPV16-E6 interaction with caspase 8.
Yuan CH; Filippova M; Tungteakkhun SS; Duerksen-Hughes PJ; Krstenansky JL
Bioorg Med Chem Lett; 2012 Mar; 22(5):2125-9. PubMed ID: 22300659
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of small molecule human papillomavirus E6 inhibitors.
Malecka KA; Fera D; Schultz DC; Hodawadekar S; Reichman M; Donover PS; Murphy ME; Marmorstein R
ACS Chem Biol; 2014 Jul; 9(7):1603-12. PubMed ID: 24854633
[TBL] [Abstract][Full Text] [Related]
3. Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV⁺ cells.
Yuan CH; Filippova M; Krstenansky JL; Duerksen-Hughes PJ
Cell Death Dis; 2016 Jan; 7(1):2060. PubMed ID: 26794656
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery.
Kolluru S; Momoh R; Lin L; Mallareddy JR; Krstenansky JL
BMC Mol Cell Biol; 2019 Aug; 20(1):30. PubMed ID: 31387520
[TBL] [Abstract][Full Text] [Related]
5. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
Ajiro M; Zheng ZM
mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
7. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis.
Filippova M; Parkhurst L; Duerksen-Hughes PJ
J Biol Chem; 2004 Jun; 279(24):25729-44. PubMed ID: 15073179
[TBL] [Abstract][Full Text] [Related]
9. A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth.
Celegato M; Messa L; Goracci L; Mercorelli B; Bertagnin C; Spyrakis F; Suarez I; Cousido-Siah A; Travé G; Banks L; Cruciani G; Palù G; Loregian A
Cancer Lett; 2020 Feb; 470():115-125. PubMed ID: 31693922
[TBL] [Abstract][Full Text] [Related]
10. Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.
Nor Rashid N; Yusof R; Watson RJ
J Gen Virol; 2011 Nov; 92(Pt 11):2620-2627. PubMed ID: 21813705
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
12. The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8.
Manzo-Merino J; Massimi P; Lizano M; Banks L
Virology; 2014 Feb; 450-451():146-52. PubMed ID: 24503077
[TBL] [Abstract][Full Text] [Related]
13. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
14. 3-(2-Chloropropyl amide)-4-methoxy-N-phenylbenzamide inhibits expression of HPV oncogenes in human cervical cancer cell.
Han F; Li Y; Lu Q; Ma L; Wang H; Jiang J; Li Z; Li Y
Virol J; 2017 Jul; 14(1):145. PubMed ID: 28754129
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
17. The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity.
Filippova M; Johnson MM; Bautista M; Filippov V; Fodor N; Tungteakkhun SS; Williams K; Duerksen-Hughes PJ
J Virol; 2007 Apr; 81(8):4116-29. PubMed ID: 17267478
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
19. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
[TBL] [Abstract][Full Text] [Related]
20. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
Divya CS; Pillai MR
Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
